Skip to main content
Marwan Sabbagh, MD, Neurology, Phoenix, AZ

Marwan Noel Sabbagh MD

Neurology•Phoenix, AZ

Neurophysiology, Neurodegenerative

Professor of Neurology, Alzheimers & Memory Disorders Division, Barrow Neurological Institute

Join to view full profile

  • 240 W Thomas Rd# 301Phoenix, AZ 85013

  • Phone+1 602-406-6262

  • Fax+1 602-406-6261

Dr. Sabbagh is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Sabbagh's full profileAlready have an account?

Summary

  • Dr. Marwan Sabbagh is a neurologist in Phoenix AZ. He received his medical degree from University of Arizona College of Medicine - Tucson and has been in practice 26 years. He specializes in neurodegenerative and is experienced in general neurology, alzheimer's disease, parkinson's disease, and behavioral neurology / neuropsychiatry.

Education & Training

  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterResidency, Neurology, 1995 - 1997
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Neurology, 1992 - 1995
  • University of Arizona College of Medicine-Phoenix
    University of Arizona College of Medicine-PhoenixInternship, Internal Medicine, 1991 - 1992
  • University of Arizona College of Medicine
    University of Arizona College of MedicineClass of 1991
  • University of California, Berkeley
    University of California, BerkeleyB.A., 1987

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1995 - Present
  • AZ State Medical License
    AZ State Medical License 1994 - 2027
  • NV State Medical License
    NV State Medical License 2018 - 2023
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012, 2014-2016
  • CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012, 2014-2016
  • WestMarc Innovator Award 2015

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Feasibility Study: Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative Diseases  
    Serrano GE, Intorcia A, Carew J, Chiarolanza G, Hidalgo JA, Sue LI, Dugger BN, Saxon-LaBelle M, Filon J, Scroggins A, Pullen J, Fornwalt BE, Scott S, Sabbagh MN, Adler..., J Neuropathol Exp Neurol, 1/30/2015
  • A phase 3 trial of whole brain and regional ß-amyloid pathology as compared to 18F-florbetaben positron emission tomography (PET)  
    Osama Sabri MD, Marwan N. Sabbagh MD, John Seibyl MD, Henryk Barthel MD,Hiroyasu Akatsu MD, Yasuomi Ouchi MD, Kohei Senda MD, Shigeo Murayama MD, Kenji Ishii MD, Masa..., Alzheimers Dement, 1/27/2015
  • Phase 3 Trial of [18F]Flutemetamol Imaging and Neuritic Plaque Density  
    Craig Curtis , Jose Gamez , Upinder Singh , Carl Sadowsky , Teresa Villena , Marwan Sabbagh , Thomas Beach , Ranjan Duara , Adam Fleisher , Kirk Frey , Zuzana Walker ,..., JAMA Neurology, 1/26/2015

Books/Book Chapters

  • Geriatric Neurology 
    Chapter: Approach to the Geriatric Neurology Patient: The Neurologic Examination. 
    Page 71 - 84Sabbagh MN, Nair AKEditors: Nair A, Sabbagh MN.Wiley, Oxford2014
  • Geriatric Neurology 
    Chapter: Amyloid imaging. 
    Page 162 - 169Nair AK, Sabbagh MNEditors: Nair A, Sabbagh MN.Wiley, Oxford2014
  • Frontiers in Drug Design and Discovery 
    Chapter: BACE1 inhibitors: attractive therapeutics for Alzheimer’s disease. 
    Page 518 - 546Decourt B, Macias M, Berk C, Sabbagh M, Adem AEditors: Ur-Rahman A, Choudhary MI.Bentham Science2014

Press Mentions

  • Alzheon Announces Peer-Reviewed Scientific Publication of Results from Pivotal APOLLOE4 Phase 3 Trial of Oral Valiltramiprosate/ALZ-801 in APOE4/4 Homozygous Individuals with Early Alzheimer’s Disease
    Alzheon Announces Peer-Reviewed Scientific Publication of Results from Pivotal APOLLOE4 Phase 3 Trial of Oral Valiltramiprosate/ALZ-801 in APOE4/4 Homozygous Individuals with Early Alzheimer’s DiseaseOctober 14th, 2025
  • NIA Funds Trial of Alzheimer’s Drug Targeting Oral Health Bacteria
    NIA Funds Trial of Alzheimer’s Drug Targeting Oral Health BacteriaAugust 22nd, 2025
  • NIA Beams $49M to Lighthouse for Bacteria-Related Alzheimer's Disease Trial
    NIA Beams $49M to Lighthouse for Bacteria-Related Alzheimer's Disease TrialAugust 22nd, 2025

Grant Support

  • Repurposing Siponimod for Alzheimer's DiseaseST. JOSEPH'S HOSPITAL AND MEDICAL CENTER2021–2027
  • MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI PatientsST. JOSEPH'S HOSPITAL AND MEDICAL CENTER2018–2025
  • Study On Thalidomide As BACE1 Inhibitor In Alzhiemer'S DiseaseNational Institute On Aging2009–2010

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Marwan Sabbagh, Dr. Marwan Sabbagh, MD, Dr. M Sabbagh, Dr. Marwan Noel Sabbagh